Telix Pharmaceuticals to Showcase Pipeline at New York R&D Day

  • Telix will host an R&D Day in New York City on September 22, 2026.
  • Event features presentations from Telix leadership and key opinion leaders.
  • Capital Markets Day scheduled for November 4, 2026, in Melbourne.

Telix Pharmaceuticals is positioning itself as a leader in targeted theranostics, leveraging its R&D Day to highlight advancements in its pipeline. The event comes amid growing competition in the radiopharmaceutical space and increasing demand for precision medicine solutions. Telix's ability to translate scientific progress into commercial success will be critical.

Pipeline Progress
How Telix's therapeutic and precision medicine pipeline advances will impact its market position.
Strategic Shifts
Whether the R&D Day reveals new strategic directions or partnerships.
Clinical Milestones
The pace at which Telix's pivotal-stage trials progress post-event.